Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors Academic Article uri icon

Overview

MeSH Major

  • Cytokines
  • Interleukin-10
  • Neoplasms
  • Polyethylene Glycols

abstract

  • AM0010 has an acceptable toxicity profile with early evidence of antitumor activity, particularly in RCC. These data support the further evaluation of AM0010 both alone and in combination with other immune therapies and chemotherapies.

publication date

  • October 10, 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2016.68.1106

PubMed ID

  • 27528724

Additional Document Info

start page

  • 3562

end page

  • 3569

volume

  • 34

number

  • 29